ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TNXP Tonix Pharmaceuticals Holding Corporation

0.17
0.01005 (6.28%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01005 6.28% 0.17 09:50:13
Open Price Low Price High Price Close Price Previous Close
0.16 0.1597 0.1703 0.1685 0.15995
more quote information »

Recent News

Date Time Source Heading
24/4/202422:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
02/4/202407:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
29/3/202400:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/3/202423:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/3/202423:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/3/202423:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/3/202423:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/3/202423:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/3/202423:05EDGAR2Form 8-K - Current report
11/3/202423:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
08/3/202401:37GLOBENew to The Street Announces TV Episode 560 with its Five..
08/3/202400:06EDGAR2Form 8-K - Current report
08/3/202400:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
07/3/202409:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
07/3/202400:05EDGAR2Form 8-K - Current report
07/3/202400:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..
06/3/202400:05EDGAR2Form 8-K - Current report
06/3/202400:00GLOBETonix Pharmaceuticals Announces Translation of Preclinical..
01/3/202409:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202400:00GLOBETonix Pharmaceuticals Announces Presentation at The 6th..
29/2/202400:06EDGAR2Form 8-K - Current report
29/2/202400:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 1..
28/2/202400:07EDGAR2Form 8-K - Current report
28/2/202400:00GLOBETonix Pharmaceuticals Announces Positive Results from..
24/2/202401:30GLOBENew to The Street Announces Line-up of its Corporate..
21/2/202400:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
17/2/202401:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
16/2/202409:02EDGAR2Form 8-K - Current report
15/2/202407:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/2/202400:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
14/2/202400:05EDGAR2Form 8-K - Current report
14/2/202400:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
13/2/202400:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
12/2/202423:06EDGAR2Form 8-K - Current report
31/1/202423:05EDGAR2Form 8-K - Current report
31/1/202423:00GLOBETonix Pharmaceuticals Announces Research Indicating..
29/1/202423:00EDGAR2Form 8-K - Current report
29/1/202423:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
26/1/202408:08EDGAR2Form 8-K - Current report
25/1/202423:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
20/1/202408:31EDGAR2Form 8-K - Current report
12/1/202408:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/1/202423:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
09/1/202409:07EDGAR2Form 8-K - Current report
09/1/202408:33EDGAR2Form DEF 14A - Other definitive proxy statements
04/1/202408:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/1/202423:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..

Your Recent History

Delayed Upgrade Clock